Viva Biotech Holdings FY 2023 Earnings: CN¥0.06 Loss Per Share

Viva Biotech Holdings: A Look into the 2023 Fiscal Year Earnings

In a striking turn of events, Viva Biotech Holdings revealed its financial results for the full year of 2023, presenting a scenario that caught the eyes of investors and industry analysts. Despite the challenging economic climate, the company reported a CN¥0.06 loss per share, a substantial improvement from a CN¥0.28 loss in FY 2022. This development indicates a significant stride towards minimizing losses and optimizing operational efficiency.